Reference values for EORTC QLQ-C30, for metastatic pancreatic cancer (mPC): Enhancing the interpretation of HRQoL scores in the POLO trial.

Hedy L. Kindler,Suvina Amin,Seongjung Joo,Nikunj Patel,Hyun Kyoo Yoo,Colin D. Johnson,Hilary Byrnes,Sara Costa-Cabral,Sandra Nolte

Reference values for EORTC QLQ-C30, for metastatic pancreatic cancer (mPC): Enhancing the interpretation of HRQoL scores in the POLO trial.

2021

Hedy L. Kindler
Suvina Amin
Seongjung Joo
Nikunj Patel
Hyun Kyoo Yoo
Colin D. Johnson
Hilary Byrnes
Sara Costa-Cabral
Sandra Nolte

393Background: Metastatic pancreatic cancer (mPC) and its treatments significantly impact patients’ (pts) health-related quality of life (HRQoL). POLO, a randomized, double-blind, placebo-controlle...

Keywords:

Oncology
Internal medicine
Medicine
Metastatic pancreatic cancer
Quality of life
reference values
eortc qlq c30

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations